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 Chapter 21 
 The Vision and Challenges of the Gene Ontology 
 Suzanna  E.  Lewis 
 Abstract 
 The overarching goal of the Gene Ontology (GO) Consortium is to provide researchers in biology and 
biomedicine with all current functional information concerning genes and the cellular context under which 
these occur. When the GO was started in the 1990s surprisingly little attention had been given to how 
functional information about genes was to be uniformly captured, structured in a computable form, and 
made accessible to biologists. Because knowledge of gene, protein, ncRNA, and molecular complex roles 
is continuously accumulating and changing, the GO needed to be a dynamic resource, accurately tracking 
ongoing research results over time. Here I describe the progress that has been made over the years towards 
this goal, and the work that still remains to be done, to make of the Gene Ontology (GO) Consortium 
realize its goal of offering the most comprehensive and up-to-date resource for information on gene 
function. 
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1  Motivation 
 From their outset in the early 1990s it was obvious that biological 
databases demanded a methodical way of describing the function 
of genes. For one thing, a model system’s  raison d ’ etre was to gain 
insight into human health and, in the days before entire genomes 
and proteomes were available, the relevant connections to human 
biology were largely based on textual descriptions of biological 
role. In conjunction, as genomes such as yeast were being com-
pleted, new laboratory techniques were being developed for sur-
veying the genome, such as microarray expression panels, and these 
data cried out for systematic description of the voluminous results. 
Finally, lest we forget, this period also saw the advent of the “World 
Wide Web.” The early pioneers in biological databases were quick 
to take advantage of the latest technologies for data dissemination 
(much easier than shipping a copy of GenBank on tape or disk 
drive as was the norm), but exchanging data in a rational and effi -
cient manner required concomitant syntactic and semantic 
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agreement. Those of us building these data resources (Including 
Amos Bairoch, Jonathan Bard, David Botstein, Michelle Gwinn, 
Minoru Kanehisa, Stan Letovsky, and Monica Riley) were avidly 
discussing what might be done. Biologists needed a way of making 
some sense of the information we were so diligently collecting 
about genes, both to locate information and to traverse across taxa. 
 Specifi cally one slightly obsessive biologist, Michael Ashburner, 
wanted to classify all fl y genes and have the corresponding worm, 
mouse, human, yeast groups use the same classifi cation scheme 
(see  ftp://ftp.ebi.ac.uk/pub/databases/edgp/misc/ashburner/
fl y_function_tree for an early example, and  ftp://ftp.geneontol-
ogy.org/pub/go/www/gene.ontology.discussion.shtml for the 
white paper as it was fi rst publicly presented in 1998). That way, if 
he found a fl y gene involved in a particular process, he could then 
ask what genes in other taxa are (thought) to be involved in the 
“same” process, and what insights can be gleaned from its counter-
part? We needed a way to describe the attributes of gene products 
in a rigorous way that would enable biologists to roam the universe 
of genomes and biology, to explore: temporally and spatially char-
acteristic expression patterns; the specifi c (often) cellular compart-
ment localization where they acted; whether they were constitutive 
parts of particular cellular components and/or complexes; and 
their biochemical or physiological functions and activities. These 
are attributes of genes that are of great interest to all biologists. 
And in an ideal world all biological databases would agree on how 
such information can be made discoverable and comparable. 
2  Desiderata (Principles) Circa 1996–1997 (Banbury & Les Treilles) 
 Two seminal workshops were organized in 1996 and 1997 largely 
devoted to discussing the need for agreement among the genomic 
resources on how semantic comparability should be achieved. The 
fi rst of these was sponsored by the Banbury Center, 1 (organized by 
M. Ashburner, E. Harlow, P. Karp and J. Witkowski), and the sec-
ond on building genome databases sponsored by the Fondation 
des Treilles 2 (organized by W.M. Gelbart, and M. Ashburner). 
These meetings set the stage for the Gene Ontology Consortium 
by defi ning our working defi nitions and essential principles. 
 These axiomatic working defi nitions, begin with “gene prod-
uct”: a physical object, typically associated with a gene or genes indi-
rectly through transcription and translation (for proteins), affecting 
some biological process. Such things as proteins, ncRNAs, protein 
complexes, and so forth are all typical functional objects. These were 
the objects to be described. In turn the essential attributes of a gene 
1
  http://www.cshl.edu/Banbury 
2
  http://www.les-treilles.com 
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product—its function, the process(es) it  participates in, and the cel-
lular location at which these occur—were also defi ned: Function 
being a capability that a physical gene product carries as a potential, 
describing only what a gene product can do, without necessarily 
specifying where or when this usage actually occurs; Process as a 
transformation that has a temporal aspect to it, even if virtually 
instantaneous, accomplished via one or more ordered assemblies of 
functions; And (originally) cellular component as an anatomical 
structure within the cell, a location in which a function or process 
occurs (since expanded to include extracellular space). 
 Following agreement on these basic defi nitions came the ani-
mated discussions on the desired (and required) characteristics for 
actual operations. 
3  Essentials for the “Ontology” 
 The name “Gene Ontology” was originally a jest, but the joke was 
on us, as it turns out GO is indeed an ontology—at least in the 
computational sense, with the primary operational data structure 
now being OWL. Every attribute mandated at the outset has 
proven its worth and remains at the core of the GO. Some of these 
essential criteria are outlined here. 
 It was rapidly understood that unique identifi ers were essential 
operationally. This allowed the collaborating resources to reference 
the ontology classes (terms) unambiguously and stably. Furthermore 
by using a semantically meaningless identifi er, as opposed to using 
the label as the identifi er, we were free to change the label at any 
time, and to display different preferred labels for different com-
munities. At the time this was a major difference compared to 
other frame based systems such as “Ontolingua” or even Ontology 
Web Language (OWL, although OWL did not exist at the time) 
which used the label (name) as the identifi er. 
 It was also determined that it would be essential for the GO terms to 
have a graphical relationship to each other, rather than the prevalent 
norm in biology at the time: a fl at list of keywords used for tagging. 
In the early, consciously simplistic, model GO began with there were 
only two relationship types:  is_a and  part_of . But it was recognized 
even then that more relationships would ultimately be required. 
 The decision to make numerical identifi ers the stable GO “object” 
had implications for the human readable labels. And, in addition, 
rather than attempting to convey all pertinent biological informa-
tion by encoding it directly into the label, human readable defi ni-
tions would provide the defi nitive defi nition. Thus it is the defi nition, 
 not the label, which defi nes an ontology class in GO. If a label 
3.1  Unique IDs
3.2  Graph Structure
3.3  Human Readable 
Defi nitions and Labels
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changes it means nothing and there are no serious consequences. 
If a defi nition changes, such that the meaning of the class has 
changed, then this has obvious consequences for any gene product 
that was annotated to the original class. Thus the original class is 
made obsolete, with a reference to the new class as a suggestion, 
and the new class is given a new identifi er. 
 Another misconception that often needs to be clarifi ed is that 
GO has nothing to do with nomenclature. The confusion arises 
because we are using (and often have to use) exactly the same 
words to describe both the product and its function. For example, 
“alcohol dehydrogenase” can describe what you can put in an 
Eppendorf tube (the gene product) or it can describe the function 
of this protein. There is, however, a formal difference—a “gene 
product” has (potentially) a many-to-many relationship with a 
“function.” That is to say there are many gene products that have 
the function “alcohol dehydrogenase” (and some of these may 
indeed be encoded by a gene with the name alcohol dehydroge-
nase, but many will not be). Moreover a particular gene product 
may have both functions “alcohol dehydrogenase” and “acetalde-
hyde dismutase” and possibly more. Since GO’s remit is describing 
functions and processes, nomenclature is irrelevant to its purpose. 
 Finally, the labels themselves are intended to be familiar to 
researchers using GO. Over the years some unfortunate “standard-
ization” efforts, have rendered terms non-user-friendly (for exam-
ple what researchers call a transcription factor is “sequence-specifi c 
DNA binding RNA polymerase II transcription factor activity” in 
the GO). The consequence is that both annotation and searching 
are made more error-prone and diffi cult because the familiar term, 
that a biologist would instinctively use, cannot be quickly located. 
The GO Consortium continues working to rectify these labeling 
issues, both by an effort to use familiar labels and through the judi-
cious use of synonyms. 
 Multiple synonyms of different fl avors are essential for allowing 
GO to deal with: colloquialisms, community preferences, abbrevia-
tions, legacy names, the multiple ways of referring to chemical ele-
ments, capitalization, and all the possible variations that occur in 
natural language. Because our top priority was communication of 
biological knowledge, we needed GO to accommodate every indi-
vidual researcher by speaking in their particular idiom. 
 In 2000 we began to maintain a history of the ontology and of 
each term. Comprehensive snapshots of both the ontology and 
the annotations are taken on a monthly basis enabling progress to 
be quantifi ed and retrospective analyses to be carried out. 
Additionally, from the outset, date stamping and authorship for 
each class were captured. Originally, and currently, the form is 
3.4  Synonyms







rather rudimentary: (Modifi ed|Added|Deleted|Split from  |Merged 
with ) by fi rstnameorinitial,surname yymmdd. This early decision 
to support “micro-attribution” remains valid, but the form is 
gradually transitioning into a more modern approach through the 
development of online editing and annotation tools with authen-
tication and authorization. 
 From the outset members of the community were asking for sub-
sets of the GO containing only the major categories and subcatego-
ries, or a branch of relevance to their particular application. These 
“Slims” enable the users to broadly group their gene products using 
a very limited set of broad categories, or confi ne themselves to spe-
cifi c branches dealing with a particular biological topic, or constrain 
the GO by a taxonomic criterion. “Slims” are handled internally by 
tagging the different GO classes as members of various categories. 
These GO subsets are used in multiple different ways: for high-level 
classifi cation; for defi ning sub-branches at the fi nest granularity; for 
clade specifi c versions; and other utility subsets. 
4  Applying the GO 
 We determined that collaborating databases would be responsible 
for attributing any functional assignment to a source (e.g., a litera-
ture reference or computational analysis) and for indicating the 
type evidence used by this attribution source. The initial set of 
“evidence codes” was primed from this short list:
 ●  Inferred from genetic interaction with  
 ●  Inferred from protein interaction with  
 ●  Inferred from sequence similarity with  
 ●  Inferred from direct assay 
 This enabled statements such as “Publication NNN” asserted 
that “gene A” has “function XYZ” by inference from a “direct 
assay.” Since this time evidence codes have developed into an 
autonomous ontology [ 1 ] and discussed in Chap.  18 [ 2 ] but the 
principle remains the same: if you are asserting that something is 
true then you must provide the evidence—its general category and 
the published reference—for making this assertion. 
 GO did not arise from nothing. Like every technology it used what 
came before it. Furthermore, given that we wanted to give attribu-
tion to our predecessors and provide a migration path for anyone 
with legacy data that had utilized these prior vocabularies. This 
practice came out of our own need as well. As the ontology was 
being built up we wanted to track some of our original sources. 
3.6  Slims
4.1  Evidence 
and Attribution
4.2  Database 
Cross-Reference
The Vision and Challenges of the Gene Ontology
296
Thus references to Monica Riley’s functional categories for  E. coli 
[ 3 ], Enzyme Commission numbers (EC— http://www.chem.
qmul.ac.uk/iubmb/enzyme/ ) and SwissProt keywords (SP— http://
www.uniprot.org/docs/keywlist ) helped to bootstrap GO at the 
outset, and additional cross-references, such as Medical Subject 
Headings (MESH— https://www.nlm.nih.gov/mesh/ ) [ 4 ], were 
added shortly thereafter to aid in interoperability. 
 Another expressivity requirement was to allow assertions stating 
that a given gene product does not hold for a given GO class. 
Experimentalists often test for an expected function, with negative 
results. Rather than lose this information we needed to provide a 
solution that could convey such negative results. Hence we pro-
vide for qualifi ers on the GO annotations. 
 Like most of the challenges facing the GO we recognized the need 
for identifying classes that are taxon specifi c in the very early years 
(1996 or earlier). The solution fi nally fell into place when the 
taxon-constraint resource and corresponding web service were 
implemented (e.g.,  http://owlservices.berkeleybop.org/isClassA
pplicableForTaxon?format=txt&idstyle=obo&id=GO:0005737&t
axid=NCBITaxon:131567 ) [ 5 ]. 
 Following the precept of test early and often, the fi rst annotation 
effort began at SGD in early 1999. Fly genes were already “anno-
tated” because these were the seeds that GO grew from. The ques-
tion was how well proto-GO, based on the needs of fl y, would 
translate to another, very different, organism. An extremely simple 
tab-delimited annotation format was devised and the dialog began. 
Similarly the fi rst automated pipeline “love-at-fi rst-sight” was 
developed by Mark Yandell in late 1999 [ 6 ,  7 ] to describe the 
genes of the newly completed fl y and human genomes. It was 
straightforward inference based on BLAST alignments, but it pro-
vided a reasonable overview of the landscape. The response to 
these fi rst efforts was overwhelmingly positive and adoption of GO 
very quickly accelerated. 
 The GO project remains focused on providing an integrated data 
resource for functional information, both experimental (Chaps.  4 
and  6 [ 8 ,  9 ]) and predicted (Chap.  5 [ 10 ]), for all known proteins, 
noncoding RNA sequences, and cellular components. In other 
words, carrying out comprehensive functional annotation is what 
drives the project, not the ontology itself. The ontology provides the 
biological model that serves as the conceptual scaffolding for the bio-
logical data. The Gene Ontology database contains currently over 
5.2 million function annotations for almost 900,000 gene products 
(mostly proteins but also some noncoding RNAs). About 660,000 of 
these annotations are based on experimental results reported in the 
4.3  Negation






published literature, and the remainder are predictions derived from 
a variety of different methods. All of which are freely available for the 
community to use. That said, there is still considerable room for 
improvement. There was, and remains, a signifi cant amount of accu-
mulated knowledge to be captured. In particular for human, the 
annotation task is still more about capturing old data than capturing 
new data because an equivalent to a Model Organism Database does 
not exist. Until the day the GO catches up it will need to capture 
existing data in parallel with capturing more recent data to achieve 
the coverage it aims for. 
5  Where We Stand Today 
 Based on the wide adoption by the community, we can claim that 
the project met a real need. The GO is a useful alternative to simple 
nomenclature, as nomenclature fails to fully convey the biology 
and is too limited to describe protein roles fully. There is still a long 
way ahead: several of the key elements that we recognized as essen-
tial in the nineties are still works in progress today. 
 In 1999 we decided at the fi rst offi cial GO meeting against imple-
menting relationships across the three branches of the GO until a 
later time. Needless to say this drastically over-simplifi ed the bio-
logical model, a simplifi cation we were fully cognizant of but one 
that allowed us to prioritize our work. In this simplistic model with 
which GO began there were only two relationship types:  is_a and 
 part_of. And even here the meaning of  part_of was confl ated, since 
 part_of in the cellular component branch of GO meant that that it 
was a sub-component while  part_of in BP meant a step or sub- 
process. Since that time we continue to work on enriching the 
Relations Ontology and applying it appropriately ( https://github.
com/oborel/obo-relations ). Currently there are eight relation-
ships in use. Most signifi cantly the three branches of the GO the 
ontologies are now being linked. 
 We did not and do not want multiple “rival” ontologies for one 
domain. The initial necessity for embedding terms within other 
terms led to the creation of numerous implicit ontologies embed-
ded within the GO (chemicals, anatomical parts, tissues, and cell 
types). In the early years, while we recognized that this might be 
dealt with by incorporating the unique identifi er that refers to the 
full defi nition elsewhere, in practice this could not be reliably 
accomplished at that time and it is taking some time to remedy. 
 Work to rectify the situation began shortly after the turn of the 
century [ 11 ] and has given rise to a small set of core ontologies, 
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which have been teased out of the GO and replaced by including 
the unique identifi er for the new class as part of the logical defi ni-
tion of the GO class. The fi rst exercise was replacing all implicit 
references to chemicals in the GO with explicit references to ChEBI 
classes [ 12 ]. Similarly the Cell Type ontology was derived from the 
GO [ 13 – 15 ] and, as an autonomous ontology, has proven its own 
value for other applications. Expression analyses and RNASeq 
experiments often draw their samples from particular cell types and 
projects such as ENCODE [ 16 ] and FANTOM [ 17 ] are using the 
cell type ontology to indicate the source cell type for their data. In 
addition, there are coordinated efforts connecting the cell line 
ontology, used in cancer studies, to the cell type ontology to indi-
cate the original cell type [ 18 ]. There is immense benefi t to con-
structing any ontology from its most element components because 
it provides a connective route across the widest possible network of 
projects. For example, RNA expression data from a cancer study 
that used a particular cell line can be automatically connected to an 
ENCODE RNA expression data from a normal cell type. 
 As regards anatomy, Jonathan Bard initially raised the question 
of how we might consider a common language for anatomy. It was 
clear that we needed a methodology for anatomical interoperability 
and querying data across our various organisms, not just for gene 
function, but ultimately for phenotypes as well. As with chemicals 
and cell types, a species-neutral anatomical ontology was extracted 
from GO, but also incorporated existing anatomical ontologies 
(e.g., mouse, zebrafi sh, fossils) thereby creating bridges between 
them [ 19 – 21 ]. Beyond its use by GO Uberon is connecting pheno-
type data, for example, from human (it is used for the logical defi ni-
tions of the Human Phenotype Ontology) to mouse (likewise there 
are logical defi nitions underlying the Mouse Phenotype ontology) 
with direct applicability to human health research [ 22 ]. 
 The challenge of comparability and interoperability can largely 
be overcome by community adoption of a small set of standard 
elemental core ontologies, from which special purpose ontologies, 
which meet the unique needs of a given project, can be constructed. 
It is hard to emphasize this enough. While the community seems 
to be blooming with a cacophony of idiosyncratic “ontologies” the 
GO is actively working to reduce the proliferation by deconstruct-
ing its terms into the elemental core set of conceptual classes 
needed to defi ne its complex terms. This approach is producing 
enormous dividends in terms of interoperability and comparability 
across widely divergent data sets. 
 The context in which a function is carried out was recognized from 
the outset as crucial. For example, the role of glucagon-mediated 
signal transduction in liver concerns gluconeogenesis, glycogenol-
ysis and plasma glucose homeostasis, whereas the role of this pro-
cess in adipose tissue is lipolysis. At the level of gene products, the 
role of cytochrome C is in oxidative phosphorylation and energy 




supply (when it is in the mitochondrion), and apoptosis (when it is 
in the cytoplasm). This has proven operationally (that is: how easy 
it is for someone to annotate) to be one of our biggest challenges 
( see Chap.  17 [ 23 ] on annotation extensions). While this has given 
curators a great deal more expressivity it still can be improved 
upon, and developing new annotation strategies and methods is 
where GO is actively working. 
6  What Lies Ahead 
 The fundamental motivation driving the GO has remained 
unchanged: we are attempting to build a realistic model of biology 
to enable research, based on the collective evidence gathered by 
the research community. As originally envisioned we needed a way 
to describe the attributes of gene products in a rigorous way that 
would enable biologists to explore the universe of genomes and 
biology. As described above we were cognizant of them all initially 
and incrementally are addressing them and taking advantage of 
technological advances as we go. 
 That said, the GO is predicated upon a reliable foundation of 
“annotation.” To gather accumulated knowledge as well as keep 
up with new research requires us to continue to seek new, more 
effi cient approaches for biologists to provide their data. This is 
one of our current big challenges. One approach is collaborative 
data exchange with other annotation initiatives. For example, 
our  collaborations with Reactome ( http://www.reactome.org/ ) 
and IntAct ( http://www.ebi.ac.uk/intact/ ) allow data from 
these resources to be incorporated into GO. Another key strat-
egy is community annotation, such as described in Chap.  7 [ 24 ], 
which has provided GO with additional annotations. Our future 
plans are to provide online community annotation tools, which 
will also be used by GO Consortium curators—tools that will 
also support refi nement of the GO itself in addition to providing 
annotations. 
 Providing a resource that captures functional data for every extant 
protein is, to say the least, a formidable challenge. One obvious 
reason is that most sequences are not, nor ever will be, experimen-
tally characterized (and not just because of volume, but also 
because some are experimentally intractable). Therefore most 
annotations must necessarily be based on predictions. Furthermore, 
for inferences to be as accurate as possible they should be predi-
cated on an explicit evolutionary framework. For the past several 
years a small group of GO curators have been using an annotation 
tool, Phylogenetic Annotation and INference Tool (PAINT) [ 25 ] 
to infer annotations among members of a protein family. PAINT 
allows curators to make precise assertions as to when functions 
were gained and lost during evolution and record the evidence 
6.1  Phylogenetic 
Annotation
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(i.e., the experimentally supported GO annotations from the leaves 
of the tree and their phylogenetic relationship to an ancestral pro-
tein) for those assertions. PAINT is as yet a stand-alone desktop 
application, but work is underway to incorporate it into a suite of 
integrated, online annotation tools for GO curators and commu-
nity contributors. Among the other tools in current development 
is one based on biological modules. 
 Biological systems are modular at many levels. For example, within a 
single domain a catalytic site may be coupled to an (allosteric) bind-
ing site that regulates the catalytic activity. Or, within a single pro-
tein different domains may form a module, e.g., the ligand binding 
domain and protein kinase domain of a transmembrane protein 
kinase receptor. And further up the size are functional modules com-
posed from subunits within a macromolecular complex (e.g., the 
ribosome). And, at an even higher level, molecular interactions can 
defi ne a pathway that can be used or reused in multiple different 
processes (e.g., the ubiquitin-dependent proteolysis pathway or 
JAK-STAT pathway). The goal of this modular approach is to defi ne 
each GO term through a combination of terms, and enable exten-
sible representation of biological modularity: how elemental molec-
ular interactions are combined in different ways to produce 
compound molecular functions, how molecular functions are com-
bined to produce processes, and how processes are combined to 
produce larger processes. A fi rst release of this curation tool (dubbed 
“Noctua” 3 ) is now being evaluated by GO curators. One notable 
feature of this new tool is that it combines the tasks of annotation 
 and ontology construction. Historically the artifi cial disconnect 
between these two inseparable tasks created serious bottlenecks, as 
annotators were forced to wait for a separate group to create or 
modify requisite terms. With Noctua the curators will more directly 
describing biology, with known relationships in the ontology associ-
ated with specifi c instances that support this model. 
7  Summary
The goal of the Gene Ontology (GO) project is to provide a uniform 
way to describe the functions of gene products from organisms across 
all kingdoms of life and thereby enable analysis of genomic data. It is 
an ongoing enterprise as our understanding of biology grows and is 
refi ned. It is a computational model of biological reality that we ulti-
mately hope every researcher will happily contribute to and regard as 
the optimum means of sharing the knowledge they have gained from 
their own research with the wider community. 
3
  Little owl ( Athene noctua ) is a bird that was sacred to the goddess  Athena , 
the Greek goddess of wisdom. 
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